methicillin-resistant staphylococcus aureus (mrsa) infections - pipeline review, h1 2014
TRANSCRIPT
www.MarketResearchReports.com
Methicillin-Resistant
Staphylococcus Aureus (MRSA)
Infections - Pipeline Review,
H1 2014
Category : Pharma & Healthcare
All logos and Images mentioned on this slide belong to their respective owners.
www.MarketResearchReports.com
Introduction to Report
Launch Date: March 31, 2014
Number of Pages: 366
Geography Coverage: Global
Available Format: PDF
Price For Single User License: USD 2,000
Price For Site License: USD 4,000
Price For Global User License: USD 6,000
Delivery Time: Within 24 Hours (During Working Days)
www.MarketResearchReports.com
About the Report
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Pipeline Review, H1 2014 provides an overview of the Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections’s therapeutic pipeline.
This report provides comprehensive information on the therapeutic development for Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases.
www.MarketResearchReports.com
Scope:
The report provides a snapshot of the global therapeutic landscape of Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections
The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
The report reviews key players involved in the therapeutics development for Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections and enlists all their major and minor projects
The report summarizes all the dormant and discontinued pipeline projects
www.MarketResearchReports.com
Scope Continues:
A review of the Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
A detailed assessment of monotherapy and combination therapy pipeline projects
Coverage of the Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections pipeline on the basis of target, MoA, route of administration and molecule type
Latest news and deals relating related to pipeline products
www.MarketResearchReports.com
Reason to Buy:
Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Develop strategic initiatives by understanding the focus areas of leading companies
Identify and understand important and diverse types of therapeutics under development for Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections
Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
Devise corrective measures for pipeline projects by understanding Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections pipeline depth and focus of Indication therapeutics
Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
www.MarketResearchReports.com
Report Coverage
1. Introduction
2. Late Stage Products
3. Drug Profiles
4. Appendix
5. Methodology
For more details regarding Report coverage see the last slide
All logos and Images mentioned on this slide belong to their respective owners.
www.MarketResearchReports.com
Company Coverage(Partial List)
1. Eli Lilly and Company
2. Genentech, Inc.
3. AmpliPhi Biosciences Corporation
4. Takeda Pharmaceutical Company Limited
5. Piramal Enterprises Limited
6. Melinta Therapeutics, Inc
7. Aphios Corporation
8. Cubist Pharmaceuticals, Inc.
9. The Medicines Company
10. Wockhardt Limited
11. Paratek Pharmaceuticals, Inc.
12. Alchemia Limited
For more details regarding Report coverage see the last slide
All logos and Images mentioned on this slide belong to their respective owners.
www.MarketResearchReports.com
Custom Research: Are you an industry professional, entrepreneur,
venture capitalist, investors and organization, then let us know your specific research requirements. Our goal is to cater to your requirements be it for a custom market research project, syndicated research report on a specific market or industry sector, newsletter creation, case study development or anything else related to marketing research.
For Any Customization Related query Visit IdeaCenter @http://www.marketresearchreports.com/idea-center
www.MarketResearchReports.com
How To Buy This Report?
Visit following URL to see Table of Content and purchase this publication:
http://mrr.cm/Zds
About Market Research Reports, Inc.Market Research Reports provides a customized set of reports from reputed Publishers, built on the intelligence available within organizations and leverages on our motto of “Intelligence Redefined”.
Contact : Amitava SenEmail : [email protected]: +1 302-703-7787 (USA) +91-8762746600 (India)